NCT (NCT) Stock Price & Analysis
NCT (NCT) rose 11.44% to USD 3.41 as of July 25, 2026 at 19:43 UTC, according to Nexqual real-time market data.
NCT last closed at USD 3.06; the session ranged USD 3.1–3.94 on volume of 1,162,973 shares. Market capitalization is —, with a 52-week range of USD 1.3–107 (NCM). Source: Nexqual, July 25, 2026 at 19:43 UTC.
Key Statistics (as of July 25, 2026 at 19:43 UTC)
| Price | USD 3.41 |
|---|---|
| Change | ▲ 11.44% (up) |
| Previous Close | USD 3.06 |
| Open | USD 3.1 |
| Day Range | USD 3.1 – 3.94 |
| 52-Week Range | USD 1.3 – 107 |
| Volume | 1,162,973 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NCT)
Nexqual's technical model rates NCT "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 19:43 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.56 (neutral) |
| vs SMA50 | Above (USD 2.95) |
| MACD | 0.03 (positive) |
Analyst Ratings (NCT)
Wall Street analysts rate NCT "None", per Nexqual as of July 25, 2026 at 19:43 UTC.
| Consensus Rating | None |
|---|
Earnings (NCT)
Source: Nexqual, July 25, 2026 at 19:43 UTC.
Financials & Fundamentals (NCT)
| Total Revenue | $24.34M |
|---|---|
| Revenue Growth (YoY) | -6.00% |
| Gross Margin | +28.84% |
| Operating Margin | -11.62% |
| Profit Margin | -1.95% |
| ROE | -2.51% |
| Debt / Equity | 59.12 |
| Current Ratio | 0.44 |
| Total Cash | $4.04M |
| Total Debt | $14.53M |
| Free Cash Flow | $-6.19M |
Source: Nexqual, July 25, 2026 at 19:43 UTC.
Financial Health Score (NCT)
Nexqual rates NCT's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 19:43 UTC.
| Growth | Weak — Revenue -6% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $4M cash vs $15M debt |
| Cash Flow | Weak — FCF negative: -$6M, burning cash |
| Efficiency | Critical — ROE -3%, ROA 1.3% |
Ownership (NCT)
| Insider Ownership | +9.52% |
|---|---|
| Institutional Ownership | +0.26% |
| Float | 400,076 |
| Short % of Float | +0.43% |
Source: Nexqual, July 25, 2026 at 19:43 UTC.
Leadership (NCT)
NCT is led by Muchun Zhu (age 41), CEO & Executive Chairman, per Nexqual as of July 25, 2026 at 19:43 UTC.
| CEO & Executive Chairman | Muchun Zhu (age 41) |
|---|---|
| CFO & Executive Director | Qingyuan Wang (age 48) |
Major Backers & Investors (NCT)
Notable institutional backers of NCT include Renaissance Technologies, Xtx Topco Ltd, Citadel, according to Nexqual as of July 25, 2026 at 19:43 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 1.15% |
| Xtx Topco Ltd | 0.26% |
| Citadel | 0.17% |
Source: Nexqual, July 25, 2026 at 19:43 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AHR | American Healthcare REIT, Inc. | USD 57.44 | ▲ 0.63% |
| RWT | Redwood Trust, Inc. | USD 4.92 | ▼ 3.15% |
| LXP | LXP Industrial Trust | USD 60.81 | ▼ 0.56% |
| BRT | BRT Apartments Corp. (MD) | USD 14.99 | ▲ 0.27% |
| NHP | National Healthcare Properties, | USD 16 | ▲ 0.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 19:43 UTC. This page is informational and not investment advice.